---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-265750"
form_type: "8-K"
ticker: "INGN"
cik: "0001294133"
company_name: "Inogen Inc"
filed_at: "2025-11-05T23:59:59+00:00"
generated_at: "2026-05-17T00:12:27.101616+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Inogen Q3 revenue $92.4M (+4% YoY); adj. EBITDA positive $2.3M; raises FY guidance

## Summary
- Revenue $92.4M, up 4% YoY; seventh consecutive quarter of mid-single-digit growth.
- GAAP net loss $5.3M vs $6.0M loss; adjusted net loss $0.5M vs $2.6M loss.
- Adjusted EBITDA $2.3M (third consecutive positive quarter); full-year adj. EBITDA guidance raised to ~$2M.
- Cash $124.5M, no debt; initiated limited U.S. release of Simeox airway clearance device.
- Gross margin 44.7% down from 46.5% due to higher B2B sales mix.

## SEC filing metadata
- accession: 0001193125-25-265750
- form_type: 8-K
- ticker: INGN
- cik: 0001294133
- company_name: Inogen Inc
- filed_at: 2025-11-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1294133/000119312525265750/0001193125-25-265750-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1294133/000119312525265750/ingn-20251105.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-265750
- JSON: https://secwatch.observer/filing/0001193125-25-265750.json
- Plain text: https://secwatch.observer/filing/0001193125-25-265750.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.